APN401
invIOs
['pioneer']
 #apn401 is a pioneering approach based on silencing the master immune checkpoint cbl-b in patients' pbmcs using #sirna. in a recently completed phase 1b trial, two heavily pre-treated patients achieved prolonged stable disease for up to six months. #aacr23 #invios
Innovative immuno-oncology means developing tomorrow's cancer therapies, today.